Cleared Abbreviated

K201743 - ClarifEye R1.0, ClarifEye Needle (FDA 510(k) Clearance)

Feb 2021
Decision
243d
Days
Class 2
Risk

K201743 is an FDA 510(k) clearance for the ClarifEye R1.0, ClarifEye Needle. This device is classified as a Interventional Fluoroscopic X-ray System (Class II - Special Controls, product code OWB).

Submitted by Philips Medical Systems Nederlands B.V. (Best, NL). The FDA issued a Cleared decision on February 23, 2021, 243 days after receiving the submission on June 25, 2020.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.1650. Interventional Fluoroscopy.

Submission Details

510(k) Number K201743 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2020
Decision Date February 23, 2021
Days to Decision 243 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code OWB — Interventional Fluoroscopic X-ray System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy

Similar Devices — OWB Interventional Fluoroscopic X-ray System

All 37
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6 with aEvolve Imaging (FOV Extension)
K253584 · Canon Medical Systems Corporation · Mar 2026
Allia Moveo
K251199 · GE Medical Systems SCS · Dec 2025
Cios Select
K250241 · Siemens Medical Solutions USA, Inc. · Nov 2025
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6 with aEvolve Imaging
K251602 · Canon Medical Systems Corporation · Oct 2025
Cios Spin
K251523 · Siemens Medical Solutions USA, Inc. · Jul 2025
Vascular Navigation PAD 2.0
K243432 · Brainlab AG · Jul 2025